Total Payments
$24,536
2024 Payments
$210.51
Companies
16
Transactions
67
Medicare Patients
417
Medicare Billing
$59,407
Payment Breakdown by Category
Other$16,750 (68.3%)
Food & Beverage$3,240 (13.2%)
Consulting$3,000 (12.2%)
Travel$1,453 (5.9%)
Education$93.34 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,750 | 13 | 68.3% |
| Food and Beverage | $3,240 | 44 | 13.2% |
| Consulting Fee | $3,000 | 1 | 12.2% |
| Travel and Lodging | $1,453 | 5 | 5.9% |
| Education | $93.34 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $18,138 | 26 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $4,314 | 5 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $764.22 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $256.54 | 5 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $232.20 | 2 | $0 (2024) |
| Shire North American Group Inc | $139.36 | 2 | $0 (2018) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $125.03 | 1 | $0 (2018) |
| Axsome Therapeutics, Inc. | $120.90 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $116.27 | 2 | $0 (2018) |
| Alkermes, Inc. | $114.99 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.51 | 6 | Neurocrine Biosciences, Inc. ($108.52) |
| 2023 | $358.28 | 6 | Janssen Pharmaceuticals, Inc ($217.51) |
| 2022 | $357.89 | 5 | Janssen Pharmaceuticals, Inc ($201.30) |
| 2020 | $22.95 | 1 | Lundbeck LLC ($22.95) |
| 2019 | $746.31 | 10 | Janssen Pharmaceuticals, Inc ($266.45) |
| 2018 | $5,244 | 11 | Allergan Inc. ($5,081) |
| 2017 | $17,596 | 28 | Allergan Inc. ($12,948) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Neuroscience | ||||||
| 08/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $108.52 | General |
| Category: Neuropsychiatry | ||||||
| 01/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Neuroscience | ||||||
| 12/13/2023 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neuroscience | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $93.23 | General |
| Category: Neuroscience | ||||||
| 04/27/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | Cash or cash equivalent | $88.31 | General |
| Category: Neurology | ||||||
| 04/27/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | Cash or cash equivalent | $32.59 | General |
| Category: Neurology | ||||||
| 02/22/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $110.58 | General |
| Category: Neuroscience | ||||||
| 01/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Neuroscience | ||||||
| 10/29/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $32.91 | General |
| Category: PSYCHOLOGY | ||||||
| 10/27/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $123.68 | General |
| Category: Neuropsychiatry | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $76.31 | General |
| Category: Neuroscience | ||||||
| 06/23/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $105.26 | General |
| Category: Neuroscience | ||||||
| 05/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neuroscience | ||||||
| 10/13/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $118.32 | General |
| Category: CNS | ||||||
| 11/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: CNS | ||||||
| 10/09/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: CNS | ||||||
| 09/17/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: CNS | ||||||
| 08/29/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: Neuroscience | ||||||
| 08/27/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 07/24/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $108.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 47 | 140 | $21,817 | $8,022 |
| 2022 | 4 | 87 | 242 | $38,697 | $15,145 |
| 2021 | 4 | 110 | 297 | $48,975 | $18,853 |
| 2020 | 6 | 173 | 333 | $42,035 | $17,388 |
Total Patients
417
Total Services
1,012
Medicare Billing
$59,407
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 140 | $21,817 | $8,022 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 189 | $28,761 | $11,736 | 40.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 11 | 12 | $3,850 | $1,853 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $2,782 | $817.54 | 29.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 28 | $3,304 | $737.86 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 174 | $26,412 | $11,470 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 46 | $9,688 | $3,129 | 32.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 18 | $5,925 | $2,634 | 44.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 20 | 59 | $6,950 | $1,620 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 147 | $14,825 | $7,272 | 49.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 52 | $8,450 | $2,609 | 30.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 34 | 67 | $7,555 | $2,556 | 33.8% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2020 | 22 | 22 | $6,600 | $2,432 | 36.8% |
| 80307 | Testing for presence of drug | Office | 2020 | 23 | 28 | $2,830 | $1,529 | 54.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 17 | $1,775 | $989.74 | 55.8% |
About Dr. Waheed Bajwa, M.D
Dr. Waheed Bajwa, M.D is a Psychiatry healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487607123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Waheed Bajwa, M.D has received a total of $24,536 in payments from pharmaceutical and medical device companies, with $210.51 received in 2024. These payments were reported across 67 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,750).
As a Medicare-enrolled provider, Bajwa has provided services to 417 Medicare beneficiaries, totaling 1,012 services with total Medicare billing of $59,407. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Cary, NC
- Active Since 05/17/2006
- Last Updated 06/01/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487607123
Products in Payments
- VRAYLAR (Drug) $18,127
- AUSTEDO (Drug) $3,570
- SD809-TD (Drug) $744.21
- SPRAVATO (Drug) $595.99
- LATUDA (Drug) $256.54
- INGREZZA (Drug) $232.20
- INVEGA SUSTENNA (Drug) $148.42
- MYDAYIS (Drug) $121.84
- Sunosi (Drug) $120.90
- ARISTADA (Drug) $114.99
- ABILIFY MAINTENA (Drug) $96.29
- NeuroStar TMS Therapy (Device) $76.00
- COBENFY (Drug) $43.27
- INVEGA TRINZA (Drug) $39.68
- QELBREE (Drug) $32.91
- BRINTELLIX (Drug) $22.95
- REXULTI (Drug) $19.98
- NUPLAZID (Drug) $19.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Cary
Haresh Tharwani, M.d, M.D
Psychiatry — Payments: $153,027
Psychiatry $153,027
Dr. Eliza Park, M.d, M.D
Psychiatry — Payments: $3,800
Psychiatry $3,800
Tiesha Panek, Pmhnp-Bc, PMHNP-BC
Psychiatry — Payments: $3,763
Psychiatry $3,763
Dr. Carol Martin, Md, MD
Psychiatry — Payments: $2,795
Psychiatry $2,795
Daniel Tan, Md, MD
Psychiatry — Payments: $1,956
Psychiatry $1,956
Dr. Stephanie Price, Do, DO
Psychiatry — Payments: $1,897
Psychiatry $1,897